Hamouda, MounaElmay, MezriSkhiri, HabibMahmoudi, Houda2026-04-102012-10Experimental and Clinical Transplantation, Cilt, 10, Sayı, 5, 2012 ss. 501-5051304-0855https://hdl.handle.net/11727/14917Gastrointestinal adverse effects are common with mycophenolate mofetil administration, especially diarrhea. We report a case of mycophenolate mofetil-related colitis in a kidney transplant recipient. Colonoscopy revealed an ulcerative diffuse colitis. The colonoscopic biopsy specimen showed mild crypt distortion, accompanied by cryptitis and focal graft-versus-host disease like changes. The patient’s symptoms improved after we discontinued the mycophenolate mofetil. A repeat colonoscopy 2 months after we discontinued the mycophenolate mofetil showed reparative changes. Mycophenolate mofetil is an important drug in organ transplant immune-suppression regimens; however, with its widespread use, additional adverse effects continue to be recognized.enImmunosuppressionColitisDiarrheaKidney transplantCase Report1052146-8427